(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1342656 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLF4 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1342656 155230825 (-)-epigallocatechin 3-gallate inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] RGD (-)-epigallocatechin 3-gallate increases response to substance EXP 6480464 KLF4 protein results in increased susceptibility to epigallocatechin gallate CTD PMID:28478070 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of KLF4 mRNA] more ... CTD PMID:28478070 (20S)-ginsenoside Rg3 decreases expression ISO RGD:1342656 6480464 ginsenoside Rg3 results in decreased expression of KLF4 mRNA CTD PMID:31916386 (S)-nicotine increases expression ISO RGD:1553264 6480464 Nicotine results in increased expression of KLF4 mRNA CTD PMID:17456735 (S)-nicotine multiple interactions ISO RGD:1553264 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1342656 6480464 o, p'-DDT results in increased expression of KLF4 mRNA CTD PMID:33728745 1,1-dichloroethene increases expression ISO RGD:1553264 6480464 vinylidene chloride results in increased expression of KLF4 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1553264 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLF4 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1553264 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1553264 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-naphthyl isothiocyanate multiple interactions ISO RGD:1342656 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of KLF4 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of KLF4 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1342656 6480464 Ethinyl Estradiol results in increased expression of KLF4 mRNA CTD PMID:18936297 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of KLF4 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:1342656 6480464 Ethinyl Estradiol affects the expression of KLF4 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of KLF4 mRNA CTD PMID:12075121 more ... 17beta-estradiol multiple interactions ISO RGD:1342656 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KLF4 mRNA, Progesterone promotes the reaction [Estradiol results in increased expression of KLF4 mRNA] CTD PMID:19619570 , PMID:21795739 17beta-estradiol increases expression ISO RGD:1342656 6480464 Estradiol results in increased expression of KLF4 mRNA CTD PMID:19619570 more ... 17beta-estradiol affects response to substance EXP 6480464 KLF4 protein affects the susceptibility to Estradiol CTD PMID:21484412 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KLF4 protein CTD PMID:21484412 17beta-estradiol multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of KLF4 protein] more ... CTD PMID:21484412 , PMID:26496021 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1342656 6480464 Dihydrotestosterone results in increased expression of KLF4 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553264 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF4 mRNA CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF4 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF4 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553264 6480464 Tetrachlorodibenzodioxin affects the expression of KLF4 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1342656 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF4 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553264 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of KLF4 mRNA] more ... CTD PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1342656 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF4 mRNA CTD PMID:12377990 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1342656 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KLF4 mRNA CTD PMID:19619570 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1342656 6480464 2 more ... CTD PMID:26705709 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1553264 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF4 mRNA more ... CTD PMID:16054899 , PMID:25559859 4,4'-sulfonyldiphenol increases expression ISO RGD:1553264 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of KLF4 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases methylation ISO RGD:1553264 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of KLF4 exon CTD PMID:33297965 5-fluorouracil increases expression ISO RGD:1342656 6480464 Fluorouracil results in increased expression of KLF4 mRNA CTD PMID:16557594 , PMID:17039268 5-fluorouracil decreases response to substance ISO RGD:1342656 6480464 KLF4 results in decreased susceptibility to Fluorouracil CTD PMID:21833590 7,12-dimethyltetraphene increases expression ISO RGD:1553264 6480464 9 more ... CTD PMID:32553695 acetamide increases expression EXP 6480464 acetamide results in increased expression of KLF4 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1342656 6480464 Acrylamide results in increased expression of KLF4 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1553264 6480464 Aflatoxin B1 results in increased expression of KLF4 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of KLF4 mRNA CTD PMID:33354967 aflatoxin B1 increases expression ISO RGD:1342656 6480464 Aflatoxin B1 results in increased expression of KLF4 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1342656 6480464 Tretinoin results in increased expression of KLF4 mRNA CTD PMID:16249480 , PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:1342656 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of KLF4 protein CTD PMID:30093655 all-trans-retinoic acid multiple interactions ISO RGD:1553264 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KLF4 mRNA CTD PMID:30951980 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 amiodarone increases expression ISO RGD:1342656 6480464 Amiodarone results in increased expression of KLF4 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KLF4 mRNA CTD PMID:16483693 angiotensin II increases expression ISO RGD:1342656 155230825 angiotensin II increases expression of KLF4 mRNA and protein in vascular smooth muscle cells RGD antirheumatic drug decreases expression ISO RGD:1342656 6480464 Antirheumatic Agents results in decreased expression of KLF4 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1342656 6480464 aristolochic acid I results in increased expression of KLF4 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:1553264 6480464 Arsenic results in decreased expression of KLF4 mRNA CTD PMID:19654921 arsane multiple interactions ISO RGD:1342656 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF4 protein CTD PMID:32802178 arsenic atom decreases expression ISO RGD:1553264 6480464 Arsenic results in decreased expression of KLF4 mRNA CTD PMID:19654921 arsenic atom multiple interactions ISO RGD:1342656 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF4 protein CTD PMID:32802178 arsenous acid decreases response to substance ISO RGD:1342656 6480464 KLF4 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid increases expression ISO RGD:1342656 6480464 Arsenic Trioxide results in increased expression of KLF4 protein CTD PMID:29486283 arsenous acid multiple interactions ISO RGD:1342656 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of KLF4 protein more ... CTD PMID:29486283 , PMID:30093655 benzene decreases expression ISO RGD:1342656 6480464 Benzene results in decreased expression of KLF4 mRNA CTD PMID:20036648 benzo[a]pyrene decreases expression ISO RGD:1553264 6480464 Benzo(a)pyrene results in decreased expression of KLF4 mRNA CTD PMID:27195522 benzo[a]pyrene increases expression ISO RGD:1342656 6480464 Benzo(a)pyrene results in increased expression of KLF4 mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:1342656 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF4 protein CTD PMID:32802178 benzo[a]pyrene increases expression ISO RGD:1553264 6480464 Benzo(a)pyrene metabolite results in increased expression of KLF4 mRNA, Benzo(a)pyrene results in increased expression of KLF4 mRNA CTD PMID:21569818 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1342656 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1553264 6480464 benzo(b)fluoranthene results in increased expression of KLF4 mRNA CTD PMID:26377693 bisphenol A affects expression ISO RGD:1342656 6480464 bisphenol A affects the expression of KLF4 mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:1553264 6480464 bisphenol A results in increased expression of KLF4 mRNA CTD PMID:32156529 bisphenol A affects methylation ISO RGD:1553264 6480464 bisphenol A affects the methylation of KLF4 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KLF4 mRNA CTD PMID:12075121 , PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of KLF4 mRNA CTD PMID:26496021 bisphenol F multiple interactions ISO RGD:1553264 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KLF4 mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1342656 6480464 butyraldehyde results in increased expression of KLF4 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1342656 6480464 Cadmium results in decreased expression of KLF4 mRNA CTD PMID:16439709 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KLF4 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:1553264 6480464 Cadmium Chloride inhibits the reaction [SP1 protein binds to SP3 protein binds to KLF4 protein binds to E2F1 protein binds to NECTIN2 promoter] CTD PMID:25046863 caffeine multiple interactions ISO RGD:1553264 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of KLF4 mRNA, Caffeine results in decreased expression of KLF4 protein CTD PMID:31306741 calcitriol increases expression ISO RGD:1342656 6480464 Calcitriol results in increased expression of KLF4 mRNA CTD PMID:16002434 cannabidiol multiple interactions ISO RGD:1342656 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of KLF4 mRNA CTD PMID:26504004 cannabidiol increases expression ISO RGD:1342656 6480464 Cannabidiol results in increased expression of KLF4 mRNA CTD PMID:26504004 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of KLF4 mRNA CTD PMID:20349343 captan increases expression ISO RGD:1553264 6480464 Captan results in increased expression of KLF4 mRNA CTD PMID:31558096 Carbaprostacyclin increases expression ISO RGD:1553264 6480464 carboprostacyclin results in increased expression of KLF4 mRNA, carboprostacyclin results in increased expression of KLF4 protein CTD PMID:25339356 carbon nanotube increases expression ISO RGD:1342656 6480464 Nanotubes more ... CTD PMID:31047983 carbonyl sulfide affects expression EXP 6480464 carbonyl sulfide affects the expression of KLF4 mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:1342656 6480464 CGP 52608 promotes the reaction [RORA protein binds to KLF4 gene] CTD PMID:28238834 chlorothalonil increases expression ISO RGD:1553264 6480464 tetrachloroisophthalonitrile results in increased expression of KLF4 mRNA CTD PMID:33246813 chlorothalonil multiple interactions ISO RGD:1553264 6480464 [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of KLF4 mRNA CTD PMID:33246813 chlorpromazine multiple interactions ISO RGD:1342656 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of KLF4 mRNA CTD PMID:27344345 chlorpromazine decreases expression ISO RGD:1342656 6480464 Chlorpromazine results in decreased expression of KLF4 mRNA CTD PMID:30703373 choline multiple interactions ISO RGD:1553264 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of KLF4 more ... CTD PMID:20938992 chromium(6+) increases expression ISO RGD:1342656 6480464 chromium hexavalent ion results in increased expression of KLF4 mRNA CTD PMID:30690063 chrysin multiple interactions ISO RGD:1342656 155230825 chrysin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] RGD ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of KLF4 mRNA CTD PMID:22193206 cisplatin decreases response to substance ISO RGD:1342656 6480464 KLF4 results in decreased susceptibility to Cisplatin CTD PMID:21833590 cisplatin increases expression ISO RGD:1342656 6480464 Cisplatin results in increased expression of KLF4 mRNA, Cisplatin results in increased expression of KLF4 protein CTD PMID:33969609 cisplatin increases expression ISO RGD:1553264 6480464 Cisplatin results in increased expression of KLF4 mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:1342656 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of KLF4 mRNA more ... CTD PMID:21833590 more ... cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of KLF4 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of KLF4 mRNA CTD PMID:20187946 copper atom decreases expression EXP 6480464 Copper results in decreased expression of KLF4 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of KLF4 mRNA CTD PMID:30556269 corticosterone multiple interactions EXP 6480464 HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA] more ... CTD PMID:31306741 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of KLF4 mRNA, Corticosterone results in decreased expression of KLF4 protein CTD PMID:31306741 coumestrol decreases expression ISO RGD:1342656 6480464 Coumestrol results in decreased expression of KLF4 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1342656 6480464 Asbestos, Crocidolite results in increased expression of KLF4 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1342656 6480464 Asbestos, Crocidolite affects the expression of KLF4 mRNA CTD PMID:25757056 cyclophosphamide decreases response to substance ISO RGD:1342656 6480464 KLF4 results in decreased susceptibility to Cyclophosphamide CTD PMID:21833590 cyclosporin A increases expression ISO RGD:1553264 6480464 Cyclosporine results in increased expression of KLF4 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1342656 6480464 Cyclosporine results in increased expression of KLF4 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:1342656 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of KLF4 mRNA CTD PMID:27344345 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of KLF4 mRNA CTD PMID:19575532 DDT decreases expression ISO RGD:1342656 6480464 DDT results in decreased expression of KLF4 mRNA CTD PMID:33728745 deoxycholic acid increases expression ISO RGD:1553264 6480464 Deoxycholic Acid results in increased expression of KLF4 mRNA CTD PMID:27151938 deoxynivalenol affects localization ISO RGD:1342656 6480464 deoxynivalenol affects the localization of KLF4 protein CTD PMID:33890134 deoxynivalenol affects expression ISO RGD:1342656 6480464 deoxynivalenol affects the expression of KLF4 protein CTD PMID:33890134 dexamethasone multiple interactions ISO RGD:1553264 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF4 mRNA more ... CTD PMID:16054899 , PMID:25559859 dexamethasone increases expression ISO RGD:1553264 6480464 Dexamethasone results in increased expression of KLF4 mRNA CTD PMID:21041162 diarsenic trioxide multiple interactions ISO RGD:1342656 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of KLF4 protein more ... CTD PMID:29486283 , PMID:30093655 diarsenic trioxide decreases response to substance ISO RGD:1342656 6480464 KLF4 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide increases expression ISO RGD:1342656 6480464 Arsenic Trioxide results in increased expression of KLF4 protein CTD PMID:29486283 dibutyl phthalate increases expression ISO RGD:1553264 6480464 Dibutyl Phthalate results in increased expression of KLF4 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid decreases expression ISO RGD:1342656 6480464 Dichloroacetic Acid results in decreased expression of KLF4 mRNA, Dichloroacetic Acid results in decreased expression of KLF4 protein CTD PMID:33405312 dichloroacetic acid multiple interactions ISO RGD:1342656 6480464 XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of KLF4 mRNA] more ... CTD PMID:33405312 diclofenac decreases expression ISO RGD:1553264 6480464 Diclofenac results in decreased expression of KLF4 mRNA CTD PMID:35537566 dieldrin increases expression ISO RGD:1342656 6480464 Dieldrin results in increased expression of KLF4 mRNA CTD PMID:31068361 diethylstilbestrol increases expression ISO RGD:1553264 6480464 Diethylstilbestrol results in increased expression of KLF4 mRNA CTD PMID:15591538 , PMID:16636312 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of KLF4 mRNA CTD PMID:22193206 dinophysistoxin 1 increases expression ISO RGD:1342656 6480464 dinophysistoxin 1 results in increased expression of KLF4 mRNA CTD PMID:28939011 dioxygen increases expression ISO RGD:1342656 6480464 Oxygen deficiency results in increased expression of KLF4 mRNA, Oxygen results in increased expression of KLF4 mRNA CTD PMID:17175027 , PMID:27103661 dioxygen decreases expression ISO RGD:1342656 6480464 Oxygen deficiency results in decreased expression of KLF4 mRNA CTD PMID:34998824 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of KLF4 mRNA, Oxygen deficiency results in decreased expression of KLF4 protein CTD PMID:28478070 dioxygen multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of KLF4 mRNA] more ... CTD PMID:28478070 dioxygen multiple interactions ISO RGD:1342656 6480464 Oxygen affects the reaction [AHR protein results in increased expression of KLF4 mRNA] CTD PMID:27103661 diuron decreases expression EXP 6480464 Diuron results in decreased expression of KLF4 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1342656 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of KLF4 mRNA CTD PMID:31307187 doxorubicin decreases expression ISO RGD:1342656 6480464 Doxorubicin results in decreased expression of KLF4 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 paeonol inhibits the reaction [Doxorubicin results in decreased expression of KLF4 mRNA] CTD PMID:31307187 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of KLF4 mRNA CTD PMID:29391264 enilconazole affects expression ISO RGD:1553264 6480464 enilconazole affects the expression of KLF4 mRNA CTD PMID:29106682 enilconazole decreases expression ISO RGD:1553264 6480464 enilconazole results in decreased expression of KLF4 mRNA CTD PMID:32814239 entinostat multiple interactions ISO RGD:1342656 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF4 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1342656 6480464 entinostat results in increased expression of KLF4 mRNA CTD PMID:26272509 ethanol increases expression EXP 6480464 Ethanol results in increased expression of KLF4 mRNA, Ethanol results in increased expression of KLF4 protein CTD PMID:29769550 ethylbenzene multiple interactions ISO RGD:1342656 6480464 [Toluene co-treated with ethylbenzene co-treated with Xylenes] results in decreased expression of KLF4 mRNA, [Toluene co-treated with ethylbenzene co-treated with Xylenes] results in increased methylation of KLF4 gene CTD PMID:26018793 etoposide multiple interactions ISO RGD:1342656 6480464 FTL protein affects the reaction [Etoposide results in increased expression of KLF4 protein] CTD PMID:33969609 etoposide increases expression ISO RGD:1342656 6480464 Etoposide results in increased expression of KLF4 mRNA, Etoposide results in increased expression of KLF4 protein CTD PMID:33969609 fenamidone increases expression ISO RGD:1553264 6480464 fenamidone results in increased expression of KLF4 mRNA CTD PMID:27029645 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 ferric oxide decreases expression ISO RGD:1553264 6480464 ferric oxide analog results in decreased expression of KLF4 mRNA CTD PMID:25086211 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of KLF4 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:1553264 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA] CTD PMID:28329830 folic acid multiple interactions ISO RGD:1553264 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folpet increases expression ISO RGD:1553264 6480464 folpet results in increased expression of KLF4 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1342656 6480464 Formaldehyde results in increased expression of KLF4 mRNA CTD PMID:20655997 , PMID:23416264 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of KLF4 protein] CTD PMID:21484412 furan increases expression EXP 6480464 furan results in increased expression of KLF4 mRNA CTD PMID:27387713 gemfibrozil multiple interactions ISO RGD:1553264 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Gemfibrozil affects the localization of KLF4 protein], KLF4 mRNA affects the reaction [Gemfibrozil results in increased expression of SOCS3 mRNA] CTD PMID:22685291 gemfibrozil affects response to substance ISO RGD:1553264 6480464 KLF4 mRNA affects the susceptibility to Gemfibrozil CTD PMID:22685291 gemfibrozil increases phosphorylation ISO RGD:1553264 6480464 Gemfibrozil results in increased phosphorylation of KLF4 protein CTD PMID:22685291 gemfibrozil affects localization ISO RGD:1553264 6480464 Gemfibrozil affects the localization of KLF4 protein CTD PMID:22685291 genistein increases expression EXP 6480464 Genistein results in increased expression of KLF4 mRNA CTD PMID:12075121 genistein multiple interactions ISO RGD:1342656 6480464 [Genistein co-treated with sulforaphane] results in decreased expression of KLF4 mRNA CTD PMID:29899271 genistein decreases expression ISO RGD:1342656 6480464 Genistein results in decreased expression of KLF4 mRNA CTD PMID:29899271 genistein affects expression ISO RGD:1342656 6480464 Genistein affects the expression of KLF4 mRNA CTD PMID:26865667 genistein increases expression ISO RGD:1342656 6480464 Genistein results in increased expression of KLF4 mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KLF4 mRNA CTD PMID:22061828 , PMID:33387578 geraniol increases expression ISO RGD:1342656 6480464 geraniol results in increased expression of KLF4 mRNA CTD PMID:27683099 glutathione increases abundance ISO RGD:1342656 6480464 KLF4 results in increased abundance of Glutathione CTD PMID:21833590 glutathione multiple interactions ISO RGD:1342656 6480464 [KLF4 results in increased expression of GCLC mRNA] which results in increased abundance of Glutathione CTD PMID:21833590 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of KLF4 mRNA CTD PMID:24915197 heparin multiple interactions EXP 6480464 Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] CTD PMID:16401727 indometacin increases expression ISO RGD:1342656 6480464 Indomethacin results in increased expression of KLF4 mRNA CTD PMID:16984733 ionomycin multiple interactions ISO RGD:1342656 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA] CTD PMID:15477007 irinotecan increases expression ISO RGD:1342656 6480464 Irinotecan analog results in increased expression of KLF4 mRNA CTD PMID:18927307 L-methionine multiple interactions ISO RGD:1553264 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of KLF4 more ... CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1342656 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of KLF4 mRNA CTD PMID:15784690 Licochalcone B increases expression ISO RGD:1342656 6480464 licochalcone B results in increased expression of KLF4 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] CTD PMID:16401727 , PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:1342656 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KLF4 mRNA CTD PMID:35811015 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of KLF4 protein] CTD PMID:21484412 LY294002 multiple interactions ISO RGD:1553264 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Gemfibrozil affects the localization of KLF4 protein] CTD PMID:22685291 manganese atom increases expression ISO RGD:1342656 6480464 Manganese results in increased expression of KLF4 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1342656 6480464 Manganese results in increased expression of KLF4 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1342656 6480464 manganese chloride results in increased expression of KLF4 mRNA CTD PMID:17175027 medroxyprogesterone acetate increases expression ISO RGD:1342656 6480464 Medroxyprogesterone Acetate results in increased expression of KLF4 mRNA CTD PMID:18497975 methylisothiazolinone increases expression ISO RGD:1342656 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KLF4 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1342656 6480464 methylmercuric chloride results in increased expression of KLF4 mRNA CTD PMID:28001369 methylseleninic acid multiple interactions ISO RGD:1342656 6480464 KLF4 protein affects the reaction [methylselenic acid results in decreased expression of CCND1 mRNA] more ... CTD PMID:18314491 methylseleninic acid increases expression ISO RGD:1342656 6480464 methylselenic acid results in increased expression of KLF4 mRNA CTD PMID:18314491 methylseleninic acid increases activity ISO RGD:1342656 6480464 methylselenic acid results in increased activity of KLF4 protein CTD PMID:18314491 methylseleninic acid affects expression ISO RGD:1342656 6480464 methylselenic acid affects the expression of KLF4 mRNA CTD PMID:14617803 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA], Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein] CTD PMID:31306741 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1342656 6480464 KLF4 protein affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of JAG1 protein] more ... CTD PMID:29611404 N-nitrosodiethylamine increases expression ISO RGD:1553264 6480464 Diethylnitrosamine results in increased expression of KLF4 mRNA CTD PMID:24535843 N-Nitrosopyrrolidine increases expression ISO RGD:1342656 6480464 N-Nitrosopyrrolidine results in increased expression of KLF4 mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] CTD PMID:16401727 , PMID:16415329 nickel dichloride increases expression ISO RGD:1342656 6480464 nickel chloride results in increased expression of KLF4 protein CTD PMID:26962057 nickel sulfate decreases expression ISO RGD:1342656 6480464 nickel sulfate results in decreased expression of KLF4 mRNA CTD PMID:16780908 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] promotes the reaction [Dronabinol results in increased expression of KLF4 mRNA] CTD PMID:31081965 nicotine increases expression ISO RGD:1553264 6480464 Nicotine results in increased expression of KLF4 mRNA CTD PMID:17456735 nicotine multiple interactions ISO RGD:1553264 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nimesulide multiple interactions ISO RGD:1553264 6480464 nimesulide inhibits the reaction [KLKB1 gene mutant form results in increased expression of KLF4 mRNA] CTD PMID:25339356 oxytocin increases expression ISO RGD:1342656 6480464 Oxytocin results in increased expression of KLF4 mRNA, Oxytocin results in increased expression of KLF4 protein CTD PMID:29104011 oxytocin multiple interactions ISO RGD:1342656 6480464 KLF4 protein promotes the reaction [Oxytocin inhibits the reaction [malondialdehyde-low density lipoprotein more ... CTD PMID:29104011 ozone increases expression EXP 6480464 Ozone results in increased expression of KLF4 mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:1553264 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KLF4 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KLF4 mRNA CTD PMID:34911549 Paeonol increases expression EXP 6480464 paeonol results in increased expression of KLF4 mRNA CTD PMID:31307187 Paeonol multiple interactions EXP 6480464 paeonol inhibits the reaction [Doxorubicin results in decreased expression of KLF4 mRNA] CTD PMID:31307187 panobinostat multiple interactions ISO RGD:1342656 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF4 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1553264 6480464 Acetaminophen results in increased expression of KLF4 mRNA CTD PMID:11264010 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KLF4 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1342656 6480464 Acetaminophen results in increased expression of KLF4 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:1553264 6480464 Acetaminophen affects the expression of KLF4 mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of KLF4 protein CTD PMID:26813466 perfluorononanoic acid increases expression ISO RGD:1342656 6480464 perfluoro-n-nonanoic acid results in increased expression of KLF4 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1553264 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KLF4 mRNA CTD PMID:36331819 phenylephrine multiple interactions EXP 6480464 Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter], SK-7041 inhibits the reaction [Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]] CTD PMID:19729022 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of KLF4 mRNA, Phenylephrine results in decreased expression of KLF4 protein CTD PMID:19729022 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1342656 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA] CTD PMID:15477007 pirinixic acid increases expression ISO RGD:1553264 6480464 pirinixic acid results in increased expression of KLF4 mRNA CTD PMID:18445702 piroxicam multiple interactions ISO RGD:1342656 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of KLF4 mRNA CTD PMID:21858171 poly(I:C) multiple interactions ISO RGD:1342656 6480464 Poly I-C promotes the reaction [MSI1 protein results in increased expression of KLF4 protein] CTD PMID:29486283 poly(I:C) increases expression ISO RGD:1342656 6480464 Poly I-C results in increased expression of KLF4 protein CTD PMID:29486283 potassium chromate multiple interactions ISO RGD:1342656 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLF4 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1342656 6480464 potassium chromate(VI) results in increased expression of KLF4 mRNA CTD PMID:22079256 , PMID:22714537 procymidone increases expression ISO RGD:1553264 6480464 procymidone results in increased expression of KLF4 mRNA CTD PMID:33246813 procymidone multiple interactions ISO RGD:1553264 6480464 [tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of KLF4 mRNA CTD PMID:33246813 progesterone multiple interactions ISO RGD:1342656 6480464 Progesterone promotes the reaction [Estradiol results in increased expression of KLF4 mRNA] CTD PMID:21795739 pyrogallol increases expression ISO RGD:1553264 6480464 Pyrogallol results in increased expression of KLF4 mRNA CTD PMID:20362636 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1342656 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA] CTD PMID:15477007 quercetin increases expression ISO RGD:1342656 6480464 Quercetin results in increased expression of KLF4 mRNA CTD PMID:21632981 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] CTD PMID:16401727 , PMID:16415329 resveratrol multiple interactions ISO RGD:1342656 6480464 resveratrol promotes the reaction [[[EGR1 protein binds to KLF4 protein] which binds to ATF3 promoter] which results in increased expression of ATF3 mRNA], resveratrol promotes the reaction [[KLF4 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA] CTD PMID:21205742 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of KLF4 mRNA CTD PMID:25905778 resveratrol increases expression ISO RGD:1342656 6480464 resveratrol results in increased expression of KLF4 mRNA, resveratrol results in increased expression of KLF4 protein CTD PMID:21205742 rimonabant multiple interactions ISO RGD:1553264 6480464 MIR466J mRNA affects the reaction [Rimonabant results in increased expression of KLF4 mRNA], Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of KLF4 mRNA] CTD PMID:30910812 rimonabant increases expression ISO RGD:1553264 6480464 Rimonabant results in increased expression of KLF4 mRNA CTD PMID:30910812 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1342656 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KLF4 mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1342656 6480464 Buthionine Sulfoximine inhibits the reaction [KLF4 results in decreased susceptibility to Cisplatin] CTD PMID:21833590 SB 203580 multiple interactions ISO RGD:1553264 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF4 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:1342656 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopolamine decreases expression EXP 6480464 Scopolamine results in decreased expression of KLF4 mRNA CTD PMID:17540011 silibinin multiple interactions ISO RGD:1553264 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF4 mRNA] CTD PMID:25559859 silibinin multiple interactions ISO RGD:1342656 155230825 silibinin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] RGD silicon dioxide decreases expression ISO RGD:1553264 6480464 Silicon Dioxide results in decreased expression of KLF4 mRNA CTD PMID:19073995 silicon dioxide increases expression ISO RGD:1342656 6480464 Silicon Dioxide analog results in increased expression of KLF4 mRNA CTD PMID:23806026 silver atom increases expression ISO RGD:1342656 6480464 Silver results in increased expression of KLF4 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1342656 6480464 Silver results in increased expression of KLF4 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:1342656 6480464 sodium arsenite results in decreased expression of KLF4 mRNA, sodium arsenite results in decreased expression of KLF4 protein CTD PMID:12377979 , PMID:23562784 sodium arsenite multiple interactions ISO RGD:1342656 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF4 protein CTD PMID:32802178 sodium arsenite decreases expression ISO RGD:1553264 6480464 sodium arsenite results in decreased expression of KLF4 mRNA CTD PMID:28370166 sodium arsenite affects expression ISO RGD:1553264 6480464 sodium arsenite affects the expression of KLF4 mRNA CTD PMID:26438402 sodium arsenite multiple interactions ISO RGD:1553264 6480464 [OGG1 gene mutant form results in increased susceptibility to sodium arsenite] which affects the expression of KLF4 mRNA CTD PMID:26438402 sodium dichromate increases expression ISO RGD:1553264 6480464 sodium bichromate results in increased expression of KLF4 mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of KLF4 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [Resveratrol co-treated with Streptozocin] results in increased expression of KLF4 mRNA, [Streptozocin co-treated with Niacinamide] promotes the reaction [Dronabinol results in increased expression of KLF4 mRNA] CTD PMID:25905778 , PMID:31081965 succimer multiple interactions ISO RGD:1553264 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF4 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KLF4 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:1342656 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KLF4 mRNA CTD PMID:26378955 sulforaphane multiple interactions ISO RGD:1342656 6480464 [Genistein co-treated with sulforaphane] results in decreased expression of KLF4 mRNA CTD PMID:29899271 taurocholic acid increases expression ISO RGD:1553264 6480464 Taurocholic Acid results in increased expression of KLF4 mRNA CTD PMID:27151938 testosterone increases expression ISO RGD:1342656 6480464 Testosterone results in increased expression of KLF4 mRNA CTD PMID:33728745 tetrachloromethane affects expression ISO RGD:1553264 6480464 Carbon Tetrachloride affects the expression of KLF4 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1553264 6480464 Carbon Tetrachloride results in increased expression of KLF4 mRNA CTD PMID:31919559 thimerosal increases expression ISO RGD:1342656 6480464 Thimerosal results in increased expression of KLF4 mRNA CTD PMID:16870260 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KLF4 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1553264 6480464 titanium dioxide results in decreased expression of KLF4 mRNA CTD PMID:27760801 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of KLF4 mRNA CTD PMID:30012374 toluene multiple interactions ISO RGD:1342656 6480464 [Toluene co-treated with ethylbenzene co-treated with Xylenes] results in decreased expression of KLF4 mRNA, [Toluene co-treated with ethylbenzene co-treated with Xylenes] results in increased methylation of KLF4 gene CTD PMID:26018793 tributylstannane increases expression ISO RGD:1553264 6480464 tributyltin results in increased expression of KLF4 mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of KLF4 mRNA CTD PMID:33387578 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of KLF4 mRNA CTD PMID:19729022 trichostatin A multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA], trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein] CTD PMID:31306741 triptonide increases expression ISO RGD:1553264 6480464 triptonide results in increased expression of KLF4 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1342656 6480464 tris(2-butoxyethyl) phosphate affects the expression of KLF4 mRNA CTD PMID:29024780 trovafloxacin decreases expression ISO RGD:1553264 6480464 trovafloxacin results in decreased expression of KLF4 mRNA CTD PMID:35537566 urethane increases expression ISO RGD:1342656 6480464 Urethane results in increased expression of KLF4 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1553264 6480464 Valproic Acid results in increased expression of KLF4 mRNA CTD PMID:19136453 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of KLF4 mRNA CTD PMID:35594946 valproic acid increases methylation ISO RGD:1342656 6480464 Valproic Acid results in increased methylation of KLF4 gene CTD PMID:28853863 , PMID:29201983 valproic acid increases expression ISO RGD:1342656 6480464 Valproic Acid results in increased expression of KLF4 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1342656 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF4 mRNA CTD PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KLF4 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of KLF4 mRNA CTD PMID:23034163 , PMID:23555832 wogonin multiple interactions ISO RGD:1342656 155230825 wogonin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] RGD wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [Estradiol results in increased expression of KLF4 protein] CTD PMID:21484412 zidovudine multiple interactions ISO RGD:1342656 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of KLF4 mRNA CTD PMID:15784690 zinc atom multiple interactions ISO RGD:1342656 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of KLF4 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1342656 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of KLF4 mRNA CTD PMID:18593933
